The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder

HIGHLIGHTS

• who: Ethan D. Borre and colleagues from the Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United have published the research work: The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder, in the Journal: PLOS ONE of February/26,/2023
• what: In this analysis, the authors assumed that clinicians, regulatory bodies, and other decision makers would not pursue implementation of a non-efficacious therapy.
• how: The authors developed a Markov microsimulation model of autism over the lifespan to compare two strategies 1) SOC . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.